Form 4: Jazz Pharmaceuticals Executive Renee D Gala Reports Stock Transaction

Renee D Gala, President & COO of Jazz Pharmaceuticals, sold 80 ordinary shares to cover tax obligations and acquired 215 shares through an employee stock purchase plan.

Summary

• Renee D Gala, President & COO of Jazz Pharmaceuticals, reported a transaction involving the company's ordinary shares.
• On December 5, 2024, 80 shares were disposed of at a price of $123.45 per share to cover tax obligations related to vesting restricted stock units.
• Additionally, 167 ordinary shares were acquired on May 31, 2024, and 48 ordinary shares were acquired on November 29, 2024, through an employee stock purchase plan.
• Following these transactions, Ms. Gala beneficially owns 55,492 ordinary shares.

Sentiment

Score: 6

Explanation: The document reflects routine stock transactions by an executive, which is neither particularly positive nor negative. The sale was for tax obligations, and the purchases were part of an employee stock plan, both of which are normal.

Positives

• The acquisition of 215 shares through the employee stock purchase plan indicates Ms. Gala's continued investment in the company.

Industry Context

This is a routine disclosure of stock transactions by a company executive, which is common practice in publicly traded companies.

Comparison to Industry Standards

• Executive stock transactions are a common occurrence in publicly listed companies like Jazz Pharmaceuticals.
• These transactions are typically disclosed via SEC Form 4 filings, which is standard practice.
• The use of employee stock purchase plans is a common method for companies to incentivize and reward employees, similar to practices at companies like Amgen and Gilead Sciences.

Stakeholder Impact

• The stock transactions have a minimal impact on shareholders as they are routine and do not indicate a change in the company's fundamentals.

Key Dates

Keywords

Jazz Pharmaceuticals, stock transaction, insider trading, Renee D Gala, employee stock purchase plan, ordinary shares, tax obligations, executive